FBCM
RNAM

Fort Baker Capital Management’s Avidity Biosciences RNAM Stock Holding History

Fort Baker Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-178,980
Closed -$12.9M – 137
2025
Q4 		$12.9M Buy
+178,980
New +$11.6M 1.41% 25

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Fort Baker Capital Management's RNAM Position: Q1 2026 in Review

Fort Baker Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 178,980 shares — an estimated $12.9M sold.

Fort Baker Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $12.9M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Fort Baker Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Fort Baker Capital Management sold 178,980 Avidity Biosciences shares in Q1 2026, an estimated $12.9M.
  • Fort Baker Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Fort Baker Capital Management's Avidity Biosciences position peaked at $12.9M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Fort Baker Capital Management's 13F filing for Q1 2026, filed 15 May 2026.